Form 4: Idexx Laboratories Inc /De Director Sells Shares
Insider Transaction (Form 4)
Lawrence D Kingsley, a Director of Idexx Laboratories Inc /De, sold 2,203 shares of common stock on September 4, 2026 for $532.08 per share.
Summary
- Option exercise/conversion: acquired 2,203 Common Stock at $114.17 ($251,517) on September 4, 2026; holds 11,771 after (Direct).
- Open-market sale: disposed of 2,203 Common Stock at $532.08 ($1,172,178) on September 4, 2026; holds 9,568 after (Direct).
- Option exercise/conversion: disposed of 2,203 Non-Qualified Stock Option (right-to-buy) on September 4, 2026 (Direct).
Sentiment
Score: 3
Explanation: StockSavvy.ai views this as a mildly negative signal: an insider sold $1,172,178 of stock on the open market.
Insider Transactions
Lawrence D Kingsley — Director
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-09-04 | Option exercise/conversion | Common Stock | 2,203 | $114 | $251.5K | 11,771 |
| 2026-09-04 | Open-market sale | Common Stock | 2,203 | $532 | $1.2M | 9,568 |
| 2026-09-04 | Option exercise/conversion | Non-Qualified Stock Option (right-to-buy) | 2,203 | — | — | 0 |
Key Dates
| Date | Description |
|---|---|
| 2026-09-04 | Option exercise/conversion (2,203 shares) |
| 2026-09-04 | Open-market sale (2,203 shares) |
| 2026-09-04 | Option exercise/conversion (2,203 shares) |
Keywords
insider transaction, Form 4, IDXX, IDEXX LABORATORIES INC /DE, bearish, Lawrence D Kingsley
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.